NephroGenex, Inc. Proceeds from Stock Options Exercised
NephroGenex, Inc. reported Proceeds from Stock Options Exercised of $5.59 thousand for the 118-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2014-05-14
- 2014-03-31: Proceeds from Stock Options Exercised 118 month $5.59K.
| Period end | Proceeds from Stock Options Exercised 118 month |
|---|---|
| 2014-03-31 | $5.59K 10-Q · filed 2014-05-14 |